(Q39921123)

15 September 2017

Anti-sclerostin antibody and mechanical loading appear to influence metaphyseal bone independently in rats (English)

1 reference

15 September 2017

1 reference

2

1 reference

15 September 2017

Fredrik Agholme

1

1 reference

15 September 2017

Xiaodong Li

series ordinal

3

1 reference

15 September 2017

Hua Zhu Ke

series ordinal

4

1 reference

15 September 2017

Per Aspenberg

series ordinal

5

1 reference

15 September 2017

1 October 2011

1 reference

15 September 2017

1 reference

15 September 2017

82

1 reference

15 September 2017

5

1 reference

15 September 2017

628-632

1 reference

Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength

15 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242963

Osteocytes and WNT: the mechanical control of bone formation.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242963

Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242963

Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242963

Beta-catenin signaling plays a disparate role in different phases of fracture repair: implications for therapy to improve bone healing

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242963

Botox induced muscle paralysis rapidly degrades bone

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242963

Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242963

Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242963

Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242963

Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242963

Texture analysis of X-ray radiographs is a more reliable descriptor of bone loss than mineral content in a rat model of localized disuse induced by the Clostridium botulinum toxin

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242963

Sclerostin antibody increases bone mass by stimulating bone formation and inhibiting bone resorption in a hindlimb-immobilization rat model

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242963

Inhibition of sclerostin by monoclonal antibody increases bone formation, bone mass, and bone strength in aged male rats

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242963

Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/beta-catenin signaling

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242963

Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242963

Bone regeneration is regulated by wnt signaling.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3242963

Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones

20 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22103277

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Sclerostin antibody treatment enhances metaphyseal bone healing in rats

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22103277

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The effects of Dickkopf-1 antibody on metaphyseal bone and implant fixation under different loading conditions

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22103277

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3109/17453674.2011.625539

1 reference

15 September 2017

1 reference

15 September 2017

PubMed publication ID

22103277

1 reference